Restasis

Restasis is a brand name of cyclosporine ophthalmic, approved by the FDA in the following formulation(s):

RESTASIS (cyclosporine - emulsion; ophthalmic)

• 
  Manufacturer: ALLERGAN
  
  Approval date: December 23, 2002
  
  Strength(s): 0.05% ^[RLD]

Has a generic version of Restasis been approved?

No. There is currently no therapeutically equivalent version of Restasis available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Restasis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Nonirritating emulsions for sensitive tissue
  Patent 5,474,979
  Issued: December 12, 1995
  Inventor(s): Ding; Shulin & Tien; Walter L. & Olejnik; Orest
  Assignee(s): Allergan, Inc.
  A pharmaceutical composition is disclosed in the form of a nonirritating emulsion which includes at least one cyclosporin in admixture with a higher fatty acid glyceride and polysorbate 80. More particularly, the cyclosporin may be cyclosporin A and the higher fatty acid glyceride may be castor oil. Composition has been found to be of a high comfort level and low irritation potential suitable for delivery of medications to sensitive areas such as ocular tissues. In addition, the composition has stability for up to nine months without crystallization of cyclosporin.
  
  Patent expiration dates:
  
  
  • May 17, 2014
    
    ✓ 
    Drug product
  
  

See also...

• Restasis Consumer Information (Drugs.com)
• Restasis Drops Consumer Information (Wolters Kluwer)
• Restasis Consumer Information (Cerner Multum)
• Restasis Advanced Consumer Information (Micromedex)
• Restasis eent AHFS DI Monographs (ASHP)
• Cyclosporine Drops Consumer Information (Wolters Kluwer)
• Cyclosporine ophthalmic Consumer Information (Cerner Multum)
• Cyclosporine Ophthalmic Advanced Consumer Information (Micromedex)
• Cyclosporine eent AHFS DI Monographs (ASHP)